MEDIFAST INC
For the period ended Nov 3, 2025. Filed Nov 3, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 3, 2025 · Filed Nov 3, 2025
Use the contents to explore the available documents and sections.
MED$12.81+0.6%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Outlook
Outlook
The company expects fourth quarter 2025 revenue to be in the range of $65 million to $80 million and fourth quarter 2025 diluted loss per share to be in the range of $0.70 to $1.25.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.